{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:56:36Z","timestamp":1760385396826,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002327","name":"SAF","doi-asserted-by":"publisher","award":["2007-62758"],"award-info":[{"award-number":["2007-62758"]}],"id":[{"id":"10.13039\/100002327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["2009-07178"],"award-info":[{"award-number":["2009-07178"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Red de Trastornos Adictivos","award":["RD06\/0001\/1006","RD06\/0001\/1001"],"award-info":[{"award-number":["RD06\/0001\/1006","RD06\/0001\/1001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.tox.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T23:18:02Z","timestamp":1412983082000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR)"],"prefix":"10.1016","volume":"326","author":[{"given":"Javier","family":"Navarro-Zaragoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Luisa","family":"Laorden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Victoria","family":"Milan\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2014.10.002_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nn.2282","article-title":"Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking","volume":"12","author":"Ambroggi","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1460-9568.2003.02434.x","article-title":"Regulation of tyrosine hydroxilase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN","volume":"17","author":"Benavides","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1471-4159.2006.04213.x","article-title":"Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis","volume":"100","author":"Bobrovskaya","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI33946","article-title":"Making a bad thing worse: adverse effects of stress on drug addiction","volume":"118","author":"Cleck","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2014.10.002_bib0025","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/npp.2011.162","article-title":"A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory","volume":"36","author":"Cornelisse","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tox.2014.10.002_bib0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/35000212","article-title":"Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion","volume":"403","author":"Delfs","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tox.2014.10.002_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1369-1600.2009.00178.x","article-title":"Mifepristone and spironolactone differently alter cocaine intravenous self-administration and cocaine-induced locomotion in C57BL\/6","volume":"15","author":"Fiancette","year":"2010","journal-title":"J. Mice Addict. Biol."},{"key":"10.1016\/j.tox.2014.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1046\/j.1460-9568.2002.02187.x","article-title":"Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal","volume":"16","author":"Frenois","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0045","first-page":"45","article-title":"Prolonged tolerance dependence and abstinence following subcutaneous morphine pellets implantation in the rat","volume":"253","author":"Gold","year":"1994","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.tox.2014.10.002_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mce.2011.06.020","article-title":"Mineralocorticoid and glucocorticoid receptors at the neuronal membrane: regulators of nongenomic corticosteroid signalling","volume":"350","author":"Groeneweg","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tox.2014.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1471-4159.2001.00521.x","article-title":"Interaction of a glucocorticoid-responsive element with regulatory sequences in the promoter region of the mouse tyrosyne hydroxylase gene","volume":"78","author":"Hagerty","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0060","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.1641-04.2004","article-title":"Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo\u2013pituitary\u2013adrenal activity after withdrawal from intermittent morphine treatment","volume":"24","author":"Houshyar","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000329988","article-title":"Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments","volume":"94","author":"Jadavji","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tox.2014.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","article-title":"The coming out of the brain mineralocorticoid receptor","volume":"31","author":"Jo\u00ebls","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2632","article-title":"The neuro-symphony of stress","volume":"10","author":"Joels","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0080","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tox.2014.10.002_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tox.2014.10.002_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","article-title":"The neurobiology of addiction: a neuroadaptational view relevant for diagnosis","volume":"101","author":"Koob","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.tox.2014.10.002_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress system in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.tox.2014.10.002_bib0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.67020443.x","article-title":"Intricate regulation of tyrosine hydroxylase activity and gene expression","volume":"67","author":"Kumer","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3565(24)39271-7","article-title":"Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1) and alpha(2)-adrenoceptors","volume":"293","author":"Laorden","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2014.10.002_bib0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1471-4159.2002.01123.x","article-title":"Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones","volume":"83","author":"Laorden","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pbb.2003.11.011","article-title":"Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission","volume":"77","author":"Leng","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tox.2014.10.002_bib0120","first-page":"4398","article-title":"Differential role of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence","volume":"12","author":"Lu","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2014.10.002_bib0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.273.5275.657","article-title":"Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB","volume":"273","author":"Maldonado","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.tox.2014.10.002_bib0130","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1210\/en.2007-0510","article-title":"Regulation of serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group. Role of ERK1\/2","volume":"148","author":"N\u00fa\u00f1ez","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2014.10.002_bib0135","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1471-4159.2006.04421.x","article-title":"Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal","volume":"101","author":"N\u00fa\u00f1ez","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0140","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2008-1732","article-title":"Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal","volume":"150","author":"N\u00fa\u00f1ez","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2014.10.002_bib0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06765.x","article-title":"Induction of FosB\/DFosB in the brain stress system-related structures during morphine dependence and withdrawal","volume":"114","author":"N\u00fa\u00f1ez","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.10.002_bib0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/mol.109.062463","article-title":"Effects of corticotropin-releasing factor receptor-1 (CRF1R) antagonists on the brain stress system responses to morphine withdrawal","volume":"77","author":"Navarro-Zaragoza","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2014.10.002_bib0155","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1476-5381.2012.01918.x","article-title":"Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal","volume":"166","author":"Navarro-Zaragoza","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2014.10.002_bib0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1476-5381.2010.01090.x","article-title":"CRF(2) mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats","volume":"162","author":"Navarro-Zaragoza","year":"2012","journal-title":"Br. J. Pharmacol."},{"year":"1988","series-title":"Maps and Guide to Microdissection of the Rat Brain","author":"Palkovits","key":"10.1016\/j.tox.2014.10.002_bib0165"},{"year":"2007","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.tox.2014.10.002_bib0170"},{"key":"10.1016\/j.tox.2014.10.002_bib0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1441.030","article-title":"Chronic stress drug use and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tox.2014.10.002_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00429-008-0191-3","article-title":"Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence","volume":"213","author":"Smith","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.tox.2014.10.002_bib0185","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1210\/endo.139.6.6029","article-title":"Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic\u2013pituitary\u2013adrenal axis activity","volume":"139","author":"Spencer","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2014.10.002_bib0190","first-page":"269","article-title":"Brain corticosteroid receptor balance in health and disease","volume":"19","author":"de Kloet","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tox.2014.10.002_bib0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X1400198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X1400198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:28:35Z","timestamp":1759534115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X1400198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"alternative-id":["S0300483X1400198X"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2014.10.002","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR)","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}